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Background: Sevoflurane is commonly usedin pediatric anesthesia due to its non-irritating airway properties, and
rapid induction and emergence. However, it is associated with emergence agitation (EA) in children. EA may cause
injury to the child or damage to the surgical site and is a cause of stress to both caregivers and families. The
efficacy of remifentanil and additional alfentanil on EA in the pediatric patients underwent ophthalmic surgery
with sevofluraneanesthesiawas not well evaluated to date. This study was designed to compare the effects of
remifentanil and remifentanil plus alfentanil on EA in children undergoing ophthalmic surgery with sevofluraneanesthesia.
Methods: Children (aged 3–9 years) undergoing ophthalmic surgery undersevoflurane anesthesia were randomly
assigned to group S (sevoflurane alone), group R (sevofluraneandremifentanil infusion, 0.1 μg/kg/min), or group
RA (sevoflurane withremifentanil infusion and intravenous injection of alfentanil 5 μg/kg 10 min before the end
of surgery). Mean arterial pressure (MAP), heart rate (HR), and sevoflurane concentration were checked every 15 min
after induction of anesthesia. The incidence of EA, time to extubation from discontinuation of sevoflurane inhalation,
and time to discharge from the postanesthesia care unit was assessed.
Results: The incidence of EA was significantly lower in groups R (32 %, 11/34; P = 0.01) and RA (31 %, 11/35; P = 0.008)
than group S (64 %, 21/33). The time to extubation was prolonged in group RA (11.2 ± 2.3 min; P = 0.004 and P = 0.016)
compared with groups S (9.2 ± 2.3 min) andR (9.5 ± 2.4 min). MAP and HR were similar in all three groups, apart from a
reduction in HR at 45 min in groups R and RA. However, the sevoflurane concentration was lower in groups R and RA
than group S (P < 0.001).
Conclusions: The administration of remifentanil to children undergoing ophthalmic surgery undersevoflurane
anesthesia reduced the incidence of EA without clinically significant hemodynamic changes. However, the
addition of alfentanil(5 μg/kg)10 min before the end of surgery provided no additional benefit compared
withremifentanil alone.
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Emergence agitation (EA) or emergence delirium defined
as “a combative, excited, and disoriented behavior that
requires transient restraint during emergence from
anesthesia”. It may cause delayed recovery and discharge
from the post anesthesia care unit (PACU), injury to the
patient and surgical site damage, makes monitoring diffi-
cult, and causes stress inboth caregivers and families [1–3].
Sevoflurane is commonly usedin pediatric anesthesia
due to its non-irritating airway properties and the rapid-
ity ofinduction and emergence from anesthesia. How-
ever, sevoflurane is associated with a relatively high
incidence of EA, ranging from 10 to 80 %, in children
[4, 5]. Ophthalmology procedures and surgery involv-
ing the tonsils, thyroid, and middle ear have been reported
to have high incidences of EA [6]. Variouspharmacological
agents, such as clonidine [5, 7], dexmedetomidine [8, 9],
fentanyl [8, 10–12], propofol [12], and ketamine [13, 14],
have been used to prevent and treat EA in children. How-
ever, their reported efficacies are various and there were
no gold-standard regimen for decreasing the EA in
pediatric patients.
Remifentanil is a potent opioid that is used widely in‘ba-
lanced’ anesthesia because of its rapid onset, very short
context-sensitive half-time, and lack of accumulation.
However, the effects of remifentanilon EA arestill contro-
versial [15–18]. In addition, there were still some concerns
about opioid-induced hyperalgesia in postoperative period
[19, 20]. The clinical usefulness of another short-acting
opioid, alfentanil, which known to decrease the incidence
of EA during emergence from isoflurane anesthesia with-
out additional postoperative side effects in adult patients
[21], was not well evaluated in pediatrics.
In this regards, we sought to evaluate the main hypoth-
esis that whether continuous remifentanil infusion de-
crease the incidence of EAand recovery characteristics in
pediatric patients underwent ophthalmic surgery with
sevoflurane anesthesia. In addition, we also testify whether
the addition of alfentanilto continuous remifentanil infu-
sion provides additional clinical benefit over remifentanil
alone which leads optimization of remifentanil usage.
Methods
This randomized, double-blind study enrolled 108
children who were classified as American Society of
Anesthesiologists physical status I or II (i.e. normal/healthy
or with mild systemic disease; http://www.asahq.org), aged
3–9 years, who were scheduled to undergo strabismus
surgery or epiblepharon repair surgery under general
anesthesia at the Department of Ophthalmology, Hallym
University Sacred Heart Hospital, College of Medicine,
Hallym University, Anyang, Republic of Korea.
Patients were excluded for any of the following
reasons: developmental delay, neurological or psychologicaldisease, history of sleep apnea, or history of general
anesthesia.
This study was approved by the Institutional Review
Board of Hallym University Sacred Heart Hospital
(reference numbers: IORG0004993, IRB00005964).
Written informed consent was obtained from the par-
ents or legal guardians.
No premedication was administered. While in the
operating room, all patients were monitored by stand-
ard limb lead electrocardiography, pulse oximetry,
non-invasive blood pressure measurements, end-tidal an-
aesthetic gas concentration, and capnography(CARES-
CAPE Monitor B650; GE Healthcare, Helsinki, Finland).
Anesthesia was induced with 5 mg/kg of thiopental
sodium intravenous (i.v.). After loss of consciousness, chil-
dren were ventilated with 3–3.5 vol. % of sevoflurane in
oxygen via a face mask and fully relaxed with 0.6 mg/kg of
rocuronium bromide i.v.. They were intubated with an
endotracheal tube of appropriate size for age. A half dose
of thiopental sodium was administered before transferring
children to the operating room in cases of children with a
separation score of 3 or 4 (Parental Separation Anxiety
Scale (PSAS);1 = excellent; separation easily, 2 = good; not
clinging, whimpers, calms with reassurance, 3 = fair; not
clinging, will not calm or quiet, 4 = poor; crying, clinging
to parent) [18]. Anesthesia was maintained with 1.5–3 %
sevoflurane and air in oxygen (FIO2 0.5). Mean arterial
pressure (MAP), heart rate (HR), and end-tidal sevoflur-
ane concentration (Et-sevo) were recorded at baseline and
15, 30, and 45 min after induction of anesthesia.
Study drugs were prepared by an anesthesiologist, who
did not participate in data collection, in 3-ml and 20-ml
syringes: normal saline with or without alfentanil in a total
volume of 2 mlin a 3-ml syringe and normal saline 20 ml
with or without 50 μg/ml of remifentanil in a 20-ml syr-
inge. Patients were randomly allocated into one of three
groups (S, R, RA) by a sealed-envelope method. Patients
in group S received continuous infusion of normal saline
from a 20-ml syringe (infusion rate comparable to remi-
fentanil0.1 μg/kg/min)from induction of anesthesia to the
end of surgery and 2 ml of normal saline10 min before the
end of surgery. Patients in group R received continuous
infusion of remifentanil(0.1 μg/kg/min) from induction to
the end of surgery and 2 ml of normal saline 10 min
before the end of surgery. Patients in group RA received
continuous infusion of remifentanil(0.1 μg/kg/min) and
5 μg/kg of alfentanil 10 min before the end of surgery.
The concentration of sevoflurane was adjusted to main-
tain blood pressure and heart rate within a 20 % deviation
from baseline values. Mechanical ventilation was adjusted
to maintain a partial pressure of end-tidal carbon dioxide
of 35–40 mmHg throughout the procedure. At the end of
surgery, sevoflurane and the study drug prepared in 20-ml
synringe (with or without remifentanil) were discontinued.
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eye patches. Antagonism of muscle relaxation was
achieved with i.v.administration of 0.05 mg/kg neostig-
mine and 0.008 mg/kg glycopyrrolate. The endotracheal
tube was removed when the patient displayed adequate
spontaneous ventilation, motor activity, and facial grim-
acing. The time to extubation(ET) was defined as the time
from the end of sevoflurane administration to removal of
the endotracheal tube. On arrival to the post-anesthetic
care unit (PACU), one of the patient’s parents stayed with
their child until discharge. Patients were discharged from
the PACU when the postanesthetic Aldrete recovery score
was ≥ 9, and the duration of PACU stay was recorded.
Demographic data andthe duration of anesthesia were re-
corded for each patient. MAP, HR, and end-tidal sevoflurane
concentration were recorded before induction of anesthesia
and at 15, 30, and 45 min after induction of anesthesia.
The primary outcome of this study was the incidence of
EA. The degree of agitation was graded on the four-point
scale ofWatcha et al. [22] (1 = calm, 2 = crying, but can be
consoled, 3 = crying, cannot be consoled, and 4 = agitated
and thrashing around) from immediately after extubation
and the highest score during emergence was used for the
evaluation. For statistical purposes, grades 3 or 4 were
considered EA. Alfentanil(5 μg/kg) was given for se-
vere agitation (grade 4) lasting longer than 5 min.
Secondary outcomes were the time to extubation and
duration of PACU stay. All data were recordedby anotherFig. 1 CONSORT diagram showing the flow of participants in present studanesthesiologist who did not know which syringe con-
tained remifentaniland which containedalfentanil.
In a preliminary study conducted in 15 patients who
received sevoflurane alone, 11 patients who underwent
pediatric ophthalmic surgery showedEA. A sample-size cal-
culation was made using a power analysis (α = 0.05, β = 0.8)
to detect a 50 % reduction of the incidenceinEA (from 73
to 37 %) and was found to require 32 patients per group.
Assuming a potential dropout rate of 10 %, the final sample
size was set at 36 patients per group. The data are
expressed as mean ± standard deviation or as numbers of
patients. All statistical analyses were performed using the
SPSS for Windows software package(SPSS Inc, IL, USA). A
one-way analysis of variance (ANOVA) was employed in
the intergroup comparisons of age, height, weight, duration
of anesthesia, extubation time, and PACU time. Sex, num-
bers of patients with separation score (≥3), incidence of EA,
and use of rescue drug were compared using a chi-square
test. MAP, HR, and End-tidal Sevoflurane concentration
were analyzed by repeated measured ANOVA and inter-
group differences at the same time points were compared
using one-way ANOVA. And all significant results were
further analyzed with the scheff ’s post hoc test. A p-value
< 0.05 was considered to indicate statistical significance.
Results
In total of 102 patients were enrolled. All patients com-
pleted the study and analyzed (Fig. 1). Demographicy
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similar among the three groups (Table 1).
There was no significant difference in MAP (P > 0.05).
Reduction of the heart rate was significant in groups R
(101.3 ± 15.2 beats/min; P < 0.001) and RA (104.2 ± 12.1
beats/min; P = 0.003) versus group S (115.5 ± 10.7 beats/
min) at 45 min after induction of anesthesia (Table 2).
End-tidal sevoflurane concentration was lower in groups
R (P < 0.001) and RA (P < 0.001) versus group S at 15,
30, and 45 min after induction of anesthesia (Table 3).
The time to extubation was significantly prolonged in
group RA (11.2 ± 2.3 min; P =0.004 and P =0.016) versus
groups S (9.2 ± 2.3 min) and R (9.5 ± 2.4), but there was
no significant group difference in the duration of PACU
stay (P > 0.05) (Table 4).
The incidence of emergence agitation in group S (21/33,
64 %) was significantly higher than groups R (11/34, 32 %;
P = 0.01) and RA (11/35, 31 %; P = 0.008). The numbers of
patients receiving rescue alfentanil in the PACU were
similar among the groups (P > 0.05) (Table 5).
Discussion
This randomized, double-blind study investigated the
effects of continuous infusion of remifentanil with or
without alfentanil given 10 min before the end of surgery
on the incidence of EA and recovery characteristics in
pediatric patients undergoing ophthalmic surgery with
sevoflurane anesthesia. The administration of continuous
remifentanilreduced the incidence of EA without clinically
significant hemodynamic changes or delay of recovery
time. However, theaddition of alfentanil(5 μg/kg) 10 min
before the end of surgery did not provide additional
clinical benefit and even delayed theextubation time.
The incidence of EA largely depends on the definition,
age, anesthetic technique, surgical procedure, and appli-
cation of adjunct medications. Generally, it ranges from
10 to 50 %, but it is reported even up to 80 % [4, 5]. The
exact mechanism of EA was not well elucidated but
excitatory current activity by sevoflurane in the locus
coeruleus of the central nervous system is one potentialTable 1 Demographic characteristics, separation score, and duration
Group S (n = 33) Grou
Age (year) 6.1 ± 2.3 6.2 ±
Height (cm) 117.6 ± 15.9 119.
Weight (kg) 24.0 ± 10.1 24.7
Sex (male/female) 16/17 17/1
Separation score (≥3) 11 (33 %) 9 (26
Duration of anesthesia (min) 75.3 ± 18.1 79.8
Data presented as mean ± SD or number of patients
Group S, patients received sevoflurane; Group R, patients received sevoflurane and
continuous infusion of remifentanil, and alfentanil given 10 min before the end of s
Separation score before transferring children to an operating room, 1 = excellent;
3 = fair; not clinging, will not calm or quiet, 4 = poor; crying, clinging to parentmechanism underlying the paradoxical excitatory effects
of sevoflurane [23, 24]. In the practice, ophthalmic pro-
cedures have been found to be associated with higher
EA as visual disturbance following surgery and eye
patching would lead to higher reactivity of the child dur-
ing awakening from anesthesia [25]. Therefore, suppres-
sion of EA is important issue for these patients for their
safety and decreasing the needs for rescue measures.
Many studies have been conducted to findthe ways to
reduce theincidence and severity of EA. One meta-
analysis found that propofol, ketamine, and preoperative
midazolam, fentanyl had prophylactic effects in prevent-
ing EA [26]. Comparing with these agents, remifentanil
has many additional clinical benefits, including rapid
onset, very short context-sensitive half-time, and lack of
accumulations [16, 17, 20]. However, the efficacy of
remifentanil on EA was not well evaluating to date.
Some results of intraoperative use of remifentanil during
adenotonsillectomy in children were promising with
significantly lower incidence of EA in sevoflurane plus
remifentanil group over sevoflurane, in line with current
study [16, 17].
On the other hand, there were some conflicting data
discouraging the use of remifentanil in this setting. The
report from Choi et al. showed that remifentanil infusion
led to a higher incidence of severe pain compared with
N2O without significant reduction in EA [15]. The
addition of remifentanil increased agitation accompanied
by a shortened recovery time in children undergoing
fiberoptic bronchoscopy under sevoflurane anesthesia
[18]. However, clinical setting of their study was aside
from surgery and their reports could not be directly
applied to the postoperative setting. In addition, Davis
et al. reported continuous infusion of remifentanilpro-
vided faster extubation times, but associated with higher
pain discomfort scores compared with bolus administra-
tion of fentanyl in pediatric patients undergoing
adenotonsillectomy [20]. However, the main contention
of their study is more effective intraoperative prophylac-
tic analgesic regimens for postoperative pain control.of anesthesia
p R (n = 34) Group RA (n = 35) P value (overall)
2.0 5.8 ± 1.9 0.772
4 ± 12.0 115.5 ± 13.1 0.500
± 7.9 22.7 ± 6.1 0.576
7 16/19 0.937
%) 10 (29 %) 0.820
± 17.8 78.1 ± 10.6 0.504
continuous infusion of remifentanil; Group RA, patients received sevoflurane,
urgery
separation easily, 2 = good; not clinging, whimpers, calms with reassurance,










T0 78.9 ± 11.9 79.4 ± 12.6 80.5 ± 9.5 0.838
T15 74.0 ± 11.3 73.4 ± 8.9 74.7 ± 8.3 0.858
T30 71.5 ± 11.1 72.4 ± 10.0 73.1 ± 7.7 0.813
T45 71.8 ± 9.5 69.91 ± 9.7 71.8 ± 8.6 0.633
HR (beats/min)
T0 112.2 ± 14.3 112.7 ± 15.4 110.2 ± 16.9 0.784
T15 118.6 ± 21.1 111.4 ± 13.9 110.8 ± 22.0 0.192
T30 115.6 ± 21.8 105.3 ± 22.5 108.5 ± 12.0 0.087
T45 115.5 ± 10.7 101.3 ± 15.2* 104.20 ± 12.1* <0.001
Data presented as mean ± SD
Group S, patients received sevoflurane; Group R, patients received sevoflurane
and continuous infusion of remifentanil; Group RA, patients received
sevoflurane, continuous infusion of remifentanil, and alfentanil given 10 min
before the end of surgery
MAP mean arterial pressure, HR heart rate, T0, T15, T30, T45 time before
induction of anesthesia, 15 min, 30 min, and 45 min after induction of
anesthesia, respectively
*P < 0.05 compared with group S









Extubation time (min) 9.2 ± 2.3 9.5 ± 2.4 11.2 ± 2.3* 0.003
PACU time (min) 18.9 ± 5.2 18.5 ± 3.8 18.1 ± 3.5 0.770
Data presented as mean ± SD or number of patients
Group S, patients received sevoflurane; Group R, patients received sevoflurane
and continuous infusion of remifentanil; Group RA, patients received
sevoflurane, continuous infusion of remifentanil, and alfentanil given 10 min
before the end of surgery
PACU postanesthesia care unit
Extubation time, time to extubation from discontinuation of
sevoflurane inhalation
PACU time, duration of PACU stay
*P < 0.05 compared with group S
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previous reports that the administration of highdose of
remifentanil to patients during surgery is associated with
a clinically small but statistically significant increase in
acute pain perception after surgery [27]. And highdo-
seintraoperative remifentanil (0.4 μg/kg/min) could
trigger postoperative hyperalgesia and anxiety com-
pared with a lower dose (0.05 μg/kg/min) [28]. Further-
more, the report fromMendel et al., which showed
alfentanil(15 μg/kg)administered during emergence from
anesthesia decreased agitation without affecting the
time to extubation in adult patients undergoing oral
surgical procedures [21]. So, we hypothesized combin-
ation of remifentanil and alfentanil may have additive
effects for reducing EA because addition of alfentail
could optimize the effect of remifentanil infusion by
preventing hyperalgesia. Unfortunately, alfentanil was
failed to prove their efficacy on postoperative EA in









Etsevo15 (Vol%) 2.5 ± 0.1 2.1 ± 0.2* 2.2 ± 0.2* < 0.001
Etsevo30 (Vol%) 2.4 ± 0.2 2.1 ± 0.2* 2.1 ± 0.2* < 0.001
Etsevo45 (Vol%) 2.3 ± 0.2 2.0 ± 0.2* 2.0 ± 0.2* < 0.001
Data presented as mean ± SD
Group S, patients received sevoflurane; Group R, patients received sevoflurane
and continuous infusion of remifentanil; Group RA, patients received
sevoflurane, continuous infusion of remifentanil, and alfentanil given 10 min
before the end of surgery
Etsevo15, Etsevo30, Etsevo45 end-tidal sevoflurane concentration at 15 min,
30 min, and 45 min after induction of anesthesia, respectively
*P < 0.05 compared with group Ssurgery, and dose of alfentanil in current study would
leads to this discrepancy. Our result could be inter-
preted as continuous remifentanil infusion itself might
enough for reducing EA.
The Pediatric Anesthesia Emergence Delirium scale,
proposed by Sikich et al., is a reliable and valid tool that
may minimize measurement error in the clinical evalu-
ation of EA. However, calculation of the incidence of
agitation with this scale is difficult. Furthermore, ithas
limited utility for the assessment of EA after ophthalmic
surgery because of the presence of an item regarding eye
contact, which may be interfered withbecause of an eye
patch or the presence of eye ointment. Thus, we used the
Watcha scale, which is a simpler toolfor use in clinical
practice and may have higher overall sensitivity and speci-
ficity than other scales [29].
The current study had several limitations. First, the
concentrations of sevoflurane were adjusted according
to vital signs but not depth of anesthesia. However,
monitoring device such as the bispectral index (BIS)
was not well validated in the field of ophthalmic sur-
gery and we believe that our approach is usual prac-
tice for many patients. Second, quantification of pain
by numeric tools such as NRS was not conducted,
which could not be accurately acquired from pediatric








Incidence of EA 21/33 (64 %) 11/34 (32 %)* 11/35 (31 %)*
Use of rescue drug 5/33 (15 %) 3/34 (8.8 %) 2/35 (6 %)
Data presented as number of patients or (%) of patients
Group S, patients received sevoflurane; Group R, patients received sevoflurane
and continuous infusion of remifentanil; Group RA, patients received
sevoflurane, continuous infusion of remifentanil, and alfentanil given 10 min
before the end of surgery
EA emergence agitation, Rescue use of rescue alfentanil during the post-
anesthesia period in patients with severe agitation (grade 4) lasting longer
than 5 min
*P < 0.05 compared with group S
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nil. Further clinical research to validate higher dose
of alfentanil to provide potentially other benefits for
the patient should be performed in the future.
Conclusions
In conclusion, intraoperative continuous infusion of
remifentanil is effective for reducing the incidence of
EA without clinically significant hemodynamic deteri-
oration or delay of the recovery time in pediatric pa-
tients undergoing ophthalmic surgery with sevoflurane
anesthesia. However, the addition of alfentanil(5 μg/kg)
10 min before the end of surgery did not provide any
additional benefit and delayed the extubation time.
Thus, intraoperative use of 0.1 μg/kg/min remifentanil
may be effective in reducing the incidence of EA in
pediatric patients undergoing ophthalmic surgery with
sevoflurane anesthesia.
Abbreviations
BIS, bispectral index; EA, emergence agitation; ET, time to extubaton; Et-sevo,
end-tidal sevoflurane concentration; HR, heart rate; MAP, mean arterial
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